Drug recall · August 14, 2013
Rifadin, Rifampin capsules recall
Why: Subpotent drug: low fill volume in some of the capsules
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Rifadin, Rifampin capsules, 150 mg, packaged in 30-count bottle, Rx only, Mfd. for Sanofi-Aventis, U.S., LLC, Bridgewater, NJ 08807, NDC 0068-0510-30
- Lots / codes
Lot # 3097657, Exp 3/15
- Quantity
- 2,462 bottles
- Company
- Sanofi US, Bridgewater, NJ
- Distribution
- Nationwide
- Initiated
- March 7, 2013 · Voluntary: Firm initiated
- Classified
- August 5, 2013
- Reported
- August 14, 2013
- Ended
- March 17, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Rifampin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.